Alzamend Neuro reported cash from operations of -$2.80M and free cash flow of -$2.80M for the quarter ended Apr 2026, down 306.2% year over year. This cash flow statement covers 25 quarters of results from Apr 2020 through Apr 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Apr2020 | Jul2020 | Oct2020 | Jan2021 | Apr2021 | Jul2021 | Oct2021 | Jan2022 | Apr2022 | Jul2022 | Oct2022 | Jan2023 | Apr2023 | Jul2023 | Oct2023 | Jan2024 | Apr2024 | Jul2024 | Oct2024 | Jan2025 | Apr2025 | Jul2025 | Oct2025 | Jan2026 | Apr2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||
| Net Income | -2.32M | -3.60M | -2.57M | -3.87M | -3.04M | -3.11M | -5.43M | -3.31M | -3.53M | -2.91M | -2.66M | -0.85M | -0.97M | -1.36M | -1.04M | -1.14M | -2.70M | -1.00M | -2.20M | -2.87M | |||||
| Share-based Compensation | 20.50M | 19.00M | 18.00M | 1.26M | 14.60M | 14.31M | 15.31M | 0.49M | 14.81M | 0.98M | 0.98M | 0.08M | 0.09M | 0.09M | 0.09M | 0.08M | 0.04M | 0.02M | 0.14M | 0.62M | |||||
| Cash from Operations | -1.22M | -2.05M | -1.78M | -1.56M | -2.54M | -2.34M | -1.81M | -2.24M | -3.30M | -1.51M | -2.03M | -1.43M | -1.06M | -3.40M | -1.42M | -0.69M | -2.36M | -1.17M | -1.74M | -2.80M | |||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||
| Amortizatization of Intangibles | 0.00M | 0.02M | -0.02M | 0.01M | |||||||||||||||||||||
| Change in Working Capital | |||||||||||||||||||||||||
| Change in Account Payables | 0.57M | -0.02M | -0.61M | 0.76M | -0.14M | -0.38M | 1.99M | 0.23M | |||||||||||||||||
| Change in Accured Expenses | -0.14M | -0.38M | 1.99M | 0.23M | -0.13M | 0.93M | 0.16M | -0.90M | -0.04M | -1.63M | -0.62M | -0.00M | 0.35M | -0.27M | 1.14M | -0.51M | |||||||||
| Other Working Capital Changes | 0.22M | -0.27M | -0.29M | -0.29M | 0.24M | -0.18M | 0.14M | -0.10M | 0.27M | -0.14M | -0.27M | -0.23M | 0.14M | 0.45M | -0.08M | -0.36M | 0.08M | -0.04M | 0.71M | 0.07M | |||||
| Investing Activities | |||||||||||||||||||||||||
| Capital Expenditures | 0.15M | 0.09M | 0.21M | ||||||||||||||||||||||
| Change in Acquisitions & Divestments | |||||||||||||||||||||||||
| Cash from Investing Activities | -0.15M | -0.09M | -0.21M | ||||||||||||||||||||||
| Financing Activities | |||||||||||||||||||||||||
| Other financing activities | 12.91M | ||||||||||||||||||||||||
| Debt Issuance and Repayment | |||||||||||||||||||||||||
| Long-Term Debt Issuances | |||||||||||||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 1.50M | 1.95M | 1.10M | 2.39M | 722.00 | 0.00M | 370.00 | 1.59M | |||||||||||||||||
| Net Equity Issued and Repurchased | 2.00M | 4.00M | 0.96M | 0.27M | 1.96M | -0.79M | 0.69M | 5.87M | 4.04M | ||||||||||||||||
| Misc. | |||||||||||||||||||||||||
| Cash from Financing Activities | 14.91M | 700.00 | 400.00 | 3.94M | 2.11M | 1.52M | 1.96M | 6.30M | 0.69M | 1.49M | 4.04M | 0.79M | |||||||||||||
| Change in Cash | 13.69M | -2.05M | -1.78M | 2.27M | -2.54M | -2.34M | -1.81M | -2.23M | -3.45M | -1.50M | 0.08M | 0.09M | 0.82M | 2.90M | -0.73M | 0.59M | 1.67M | -1.17M | -1.74M | -2.00M | |||||
| Free Cash Flow | -1.22M | -2.05M | -1.78M | -1.56M | -2.54M | -2.34M | -1.81M | -2.24M | -3.45M | -1.51M | -2.03M | -1.43M | -1.15M | -3.40M | -1.42M | -0.90M | -2.36M | -1.17M | -1.74M | -2.80M | |||||
| Net Cash Flow | 13.69M | -2.05M | -1.78M | 2.38M | -2.54M | -2.34M | -1.81M | -2.24M | -3.45M | -1.51M | 0.08M | 0.09M | 0.82M | 2.90M | -0.73M | 0.59M | 1.67M | -1.17M | -1.74M | -2.00M |